Skip to content

The Effect of Obesity Factors on the Dose-Response Relationship of Remimazolam Combined with Remifentanil in Procedural Sedation for Pediatric Daytime Circumcision

The Effect of Obesity Factors on the Dose-Response Relationship of Remimazolam Combined with Remifentanil in Procedural Sedation for Pediatric Daytime Circumcision

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110458
Enrollment
Unknown
Registered
2025-10-14
Start date
2025-10-31
Completion date
Unknown
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity,prepuce of children

Interventions

Normal Group:Drug sedation at the corresponding dose obtained by the normal weight sequential method.
Obese Group:Sedation with drugs at the corresponding dose obtained according to the sequential method for obese body wei.

Sponsors

Ningbo University Affiliated Women and Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
6 Years to 18 Years

Inclusion criteria

Inclusion criteria: ASA I-II,aged 6-18 yearsBMI <= 35 kg/m^2,scheduled for elective pediatric daytime circumcision,;no history of mental illnesses such as epilepsy.

Exclusion criteria

Exclusion criteria: Contraindications to dorsal penile nerve block puncture,complicated with severe congenital medical diseases, complicated with a history of mental illnesses such as epilepsy;preoperative administration of sedatives,Allergic to the drugs used in the study.

Design outcomes

Primary

MeasureTime frame
Sequential drug dosage;Duration of awakening;

Secondary

MeasureTime frame
Basic vital signs: Blood pressure, heart rate, pulse, oxygen saturation;Total duration of procedural sedation;Operation time of dorsal penile nerve block;

Countries

China

Contacts

Public ContactTiantian Liu

Ningbo University Affiliated Women and Children's Hospital

Liutiantian8385@163.com+86 137 3885 4907

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026